2.4. Expression Vector Constructs and Stable Transfection

KT Ke-Hung Tsui
KC Kang-Shuo Chang
HS Hsin-Ching Sung
SH Shu-Yuan Hsu
YL Yu-Hsiang Lin
CH Chen-Pang Hou
PY Pei-Shan Yang
CC Chien-Lun Chen
TF Tsui-Hsia Feng
HJ Horng-Heng Juang
request Request a Protocol
ask Ask a question
Favorite

The expression vector containing the coding region of human MALT1 cDNA (HG11618-UT) and control pCMV3 vector were purchased from Sino Biological Inc. (Beijing, China). The pCMV-IκBαM, an inhibitor of NF-κB expression vector, contains two mutations at residues 32 and 36 of serine to alanine that prevent phosphorylation (Cat. no. 631923; Clontech Laboratories, Inc.; Mountain View, CA, USA). The constructs of NIK (MAP3K14) expression vector (pcDNA-NIK) and control pcDNA3 expression vector were described in the previous studies [31]. The expression vectors were introduced into prostate carcinoma cells by electroporation using the ECM 830 (BTX, Holliston, MA, USA) set on a single pulse setting, 70 msec, and 180 V. The mock-transfection cells were transfected with control pCMV3 or pcDNA3 expression vectors and were clonally selected in the same manner as the gene-overexpression cells.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A